Bausch Health Companies Inc BHC-CA:Toronto Stock Exchange

*Data is delayed | Exchange | CAD
Last | 04/22/24 EDT
11.58UNCH (UNCH)
52 week range
7.56 - 15.43
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close11.58
  • 52 Week High15.43
  • 52 Week High Date04/03/24
  • 52 Week Low7.56
  • 52 Week Low Date05/12/23

Key Stats

  • Market Cap3,179.44M
  • Shares Out366.67M
  • 10 Day Average Volume453,507.6
  • Dividend-
  • Dividend Yield-
  • Beta0.35
  • YTD % Change8.94

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close11.58
  • 52 Week High15.43
  • 52 Week High Date04/03/24
  • 52 Week Low7.56
  • 52 Week Low Date05/12/23
  • Market Cap3,179.44M
  • Shares Out366.67M
  • 10 Day Average Volume453,507.6
  • Dividend-
  • Dividend Yield-
  • Beta0.35
  • YTD % Change8.94

RATIOS/PROFITABILITY

  • EPS (TTM)-2.15
  • P/E (TTM)-5.39
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date05/17/2007
  • Div Amount0.375
  • Split Date-
  • Split Factor-

Profile

MORE
Bausch Health Companies Inc. is a global diversified pharmaceutical company. The Company develops, manufactures, and markets a range of products primarily in gastroenterology (GI), hepatology, neurology, dermatology, eye health, and others, through Bausch + Lomb Corporation. Its Salix segment consists of sales in the United States of GI products. Its International segment consists of sales, with the exception of sales of Bausch + Lomb products and Solta Medical aesthetic...
John Paulson
Independent Chairman of the Board
Thomas Appio
Chief Executive Officer, Director
John Barresi
Interim Chief Financial Officer
Seana-Lyn Carson
Executive Vice President, General Counsel
Address
2150 Saint-Elzear Blvd W
Laval, QC
H7L 4A8
Canada

Top Peers

SYMBOLLASTCHG%CHG
GUD
CPH
HLS
RX
Biosyent Inc
8.40UNCHUNCH
MDP